GFAP and early-onset autosomal dominant Alzheimer disease: When binarizing subjects according to biomarker positivity in AT profiles, it is possible to observe that individuals without the presence of Alzheimer's disease pathology have significantly lower plasma GFAP levels than patients with Alzheimer's disease pathology.